We are seeking an early-career faculty member to expand our portfolio of research on HIV prevention and sexual health. Our department is a warm and supportive place to work and our team laughs a ton. Please spread the word in your networks! populationmedicine.org/about/faculty_…

To all the postdocs at #SER2023: it's not too late to apply for this position! I'm heading home today but feel free to DM or email me with any questions. #epitwitter

Perspective piece by Julia Marcus, PhD, MPH and Douglas S Krakower in NEJM shares a vision for OTC PrEP (and perhaps bundling it with OTC HIV tests) 👏 nejm.org/doi/full/10.10…

Several barriers to access to preexposure prophylaxis for HIV could be alleviated by making it available over the counter. This step could particularly facilitate access among groups that face stigma. Read the Perspective by Douglas S Krakower, M.D., and Julia Marcus, PhD, MPH, Ph.D.:

Timely and provocative -- excellent perspective by Julia Marcus, PhD, MPH & Douglas S Krakower on how making #PrEP OTC will improve access for all #FreeThePrEP nejm.org/doi/full/10.10…

#PrEP reduces anxiety, increases intimacy and leads to more pleasurable sex, but these values-based outcomes are neglected in PrEP resources. In The Lancet HIV we argue for better integration of potential user-reported benefits in PrEP training & guidelines authors.elsevier.com/a/1hZac8MsVoa8…

Been saying this for years in our trainings and now have a new resource!! Love this article by Michael Traeger Julia Marcus, PhD, MPH about values based PrEP resources for uptake and retention. #StopHIVTogether #HIVTwitter #IDTwitter

#PrEP uptake is suboptimal. One problem is the difficulty providers have in supporting their patients' #sexual well-being. Michael Traeger Julia Marcus, PhD, MPH Douglas S Krakower and I discuss how to prioritize patients' experiences in this week's @LancetHIV sciencedirect.com/science/articl…

.Douglas S Krakower, M.D., discusses the potential benefits associated with making preexposure prophylaxis for HIV available without a prescription. Listen to the full interview: nej.md/47ihO0h

#doxyPEP is a game changer for STIs, but guidelines need to balance benefits with potential harms. We explored potential prescribing strategies & found that prescribing doxyPEP to people with recent STIs could maximise efficiency for preventing future STIs bit.ly/3QNwoqM

Julia Marcus, PhD, MPH Michael Traeger and I summarize the evidence for #Doxycycline #PEP to prevent bacterial #STI in JAMA. Makes sense for #MSM and #transgender #women at risk for #STI. Need more data for cisgender women jamanetwork.com/journals/jama/…

🆕️⚡️⚡️Reciew article JAMA Ken Mayer Michael Traeger Julia Marcus, PhD, MPH Doxycycline Postexposure Prophylaxis and Sexually Transmitted Infections #DoxyPEP #IDXposts jamanetwork.com/journals/jama/…

It's not enough for clinical prediction models to be accurate—they need to be trusted by providers. In NEJM Catalyst, we share lessons learned from implementing a prediction model for PrEP in community health centers. Douglas S Krakower Miguel Marino PhD 🇲🇽 🇺🇸 Ken Mayer catalyst.nejm.org/doi/full/10.10…

An #EHR-based intervention guided by #HIV risk prediction model ⬆️ #PrEP initiation among PCPs who also care for people with HIV. New in #JAIDS from Jonathan Volk et al k-p.li/3uOiOL7 bit.ly/3SXjnu0 Michael Silverberg Julia Marcus, PhD, MPH KPNorthernCal PermanenteDoctors

We surveyed LGBT+ folks across the US last year, prior to CDC #doxyPEP draft guidelines: 95%(!) were interested in using antibiotics to prevent STIs and 13% recently used doxyPEP. Concerns & motivations for doxyPEP use and contexts where it was used varied. Our #CROI2024 poster:

A reminder that words matter when talking about sex and sexual behaviors. Julia Marcus, PhD, MPH and Johnathan Snowden's paper is even more important today than when initially published. We don't have to call sex "risky" or "unsafe" when we mean condomless. journals.lww.com/stdjournal/ful…

Out today in STD Journal. Use of #doxyPEP and other antibiotics for STI prevention among gay and bi men+ in the US. Among >900 respondents, 21% had ever used antibiotics for STI prevention and almost all were interested. journals.lww.com/stdjournal/abs…